Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsAMEXEnergyOil & Gas Exploration & ProductionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CKX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Free cash flow yield stays near or above 1% | A supporting condition in CKX Lands Inc's published investment case. The stated target is >= 1%. | Broken | free cash flow yield falls below 1% | Free cash flow yield: -0.46% As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 2026-0.46 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CKX is a cyclical energy business with robust earnings quality, stable management, and a supportive sector backdrop. Its current long-term thesis is on watch: recent performance is neutral and below its industry cohort, while the strategic alternatives review is still at an early stage.
The valuation evidence is mixed: CKX is described as cheap versus peers, yet the model also shows a 42% premium versus peers and an expectations gap of -0.34. The priced-in assessment calls the setup justified and says only a turbulent sector regime is reflected, not a broader combination of expensive valuation, weak performance, and turbulence.
Near term, fundamentals look neutral, with recent performance below the industry cohort but not described as freshly broken. Management has continued a review of strategic alternatives, including a possible asset or company sale, but there are no further results tied to that effort yet. Elevated risk remains, and the evidence does not establish a clear operating trend beyond these points.
The multi-year view partly hinges on whether the strategic review produces a meaningful outcome; that process remains early, with mixed evidence so far. Near term, continued strength or weakness in energy bellwethers such as COP, EOG, and OXY could shape the sector backdrop for CKX. A further weakening in jobs data could also increase recession concerns and weigh more heavily on cyclical energy names.
CKX has solid earnings quality and a sector tailwind, but its expensive valuation signal, elevated risks, and below-cohort recent performance leave the 1-to-3-year thesis unresolved. The strategic review and energy-sector conditions are the main swing factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
PE ratio remains below peer median of 16.17 | A supporting condition in CKX Lands Inc's published investment case. The stated target is <= 16.17. | Intact | PE ratio rises above peer median without earnings improvement | P/E (TTM): 7.43x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 20267.428 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth remains above -55% next year | A primary condition in CKX Lands Inc's published investment case. The stated target is >= -55% YoY. | Intact | revenue growth falls below -55% next year | Revenue growth: 23.82% FY2026-Q2; GAAP. Published target: >= -55% YoY. Target period is not explicitly aligned with this observation. Aug 7, 202623.818562 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.